{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:35Z","timestamp":1786118915647,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/fbp.0b013e3282fe8888","type":"journal-article","created":{"date-parts":[[2008,5,7]],"date-time":"2008-05-07T03:05:52Z","timestamp":1210129552000},"page":"197-209","source":"Crossref","is-referenced-by-count":58,"title":["Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats"],"prefix":"10.1097","volume":"19","author":[{"given":"Paola","family":"Maccioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro A.M.","family":"Carai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Gessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210202","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s002130050326","article-title":"Selective inhibition of sucrose and alcohol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors","volume":"132","author":"Arnone","year":"1997","journal-title":"Psychopharmacology"},{"key":"R2-4-20210202","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1523\/JNEUROSCI.22-11-04709.2002","article-title":"Differential expression of motivational stimulus properties by dopamine in nucleus accumbens shell versus core and prefrontal cortex","volume":"22","author":"Bassareo","year":"2002","journal-title":"J Neurosci"},{"key":"R3-4-20210202","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0166-2236(03)00233-9","article-title":"Parsing reward","volume":"26","author":"Berridge","year":"2003","journal-title":"Trends Neurosci"},{"key":"R4-4-20210202","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.lfs.2005.04.017","article-title":"Rimonabant: the first therapeutically relevant cannabinoid antagonist","volume":"77","author":"Carai","year":"2005","journal-title":"Life Sci"},{"key":"R5-4-20210202","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1527-3458.2006.00091.x","article-title":"Efficacy of rimonabant and other cannabinoid CB1 receptor antagonists in reducing food intake and body weight: preclinical and clinical data","volume":"12","author":"Carai","year":"2006","journal-title":"CNS Drug Rev"},{"key":"R6-4-20210202","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00008877-200209000-00018","article-title":"SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats","volume":"13","author":"Cohen","year":"2002","journal-title":"Behav Pharmacol"},{"key":"R7-4-20210202","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12035-007-0017-y","article-title":"The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence","volume":"36","author":"Colombo","year":"2007","journal-title":"Mol Neurobiol"},{"key":"R8-4-20210202","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainresrev.2005.10.004","article-title":"Cannabinoids, opioids and eating behavior: the molecular face of hedonism?","volume":"51","author":"Cota","year":"2006","journal-title":"Brain Res Rev"},{"key":"R9-4-20210202","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despr\u00e9s","year":"2005","journal-title":"N Engl J Med"},{"key":"R10-4-20210202","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.tips.2005.06.002","article-title":"Cannabinoid CB1 receptors control conditioned drug seeking","volume":"26","author":"De Vries","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"R11-4-20210202","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2003.10.012","article-title":"Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist\/inverse agonist SR141716A","volume":"483","author":"De Vry","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"R12-4-20210202","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/FBP.0b013e32801456c6","article-title":"The effects of anorexic drugs on free-fed rats responding under a second-order FI15-min (FR10:S) schedule for high incentive foods","volume":"18","author":"Evenden","year":"2007","journal-title":"Behav Pharmacol"},{"key":"R13-4-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2006.05.003","article-title":"An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives","volume":"53","author":"Fattore","year":"2007","journal-title":"Brain Res Rev"},{"key":"R14-4-20210202","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00213-006-0327-1","article-title":"Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats","volume":"185","author":"Gessa","year":"2006","journal-title":"Psychopharmacology"},{"key":"R15-4-20210202","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-8993(01)02451-9","article-title":"Accumbens dopamine mechanisms in sucrose intake","volume":"904","author":"Hajnal","year":"2001","journal-title":"Brain Res"},{"key":"R16-4-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.npp.1301034","article-title":"Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference","volume":"32","author":"Hansson","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R17-4-20210202","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00213-002-1263-3","article-title":"Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after \u03949-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716","volume":"165","author":"Higgs","year":"2003","journal-title":"Psychopharmacology"},{"key":"R18-4-20210202","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.physbeh.2005.08.033","article-title":"Effect of \u03949-tetrahydrocannabinol on sucrose palatability as measured by the taste reactivity test","volume":"86","author":"Jarrett","year":"2005","journal-title":"Physiol Behav"},{"key":"R19-4-20210202","first-page":"378","article-title":"Neurobiology of addiction","author":"Koob","year":"2006"},{"key":"R20-4-20210202","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1530-0277.2001.tb02353.x","article-title":"Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration","volume":"25","author":"Lallemand","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"R21-4-20210202","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1901\/jeab.2004.82-275","article-title":"Effects of anorectic drugs on food intake under progressive-ratio and free-access conditions in rats","volume":"82","author":"LeSage","year":"2004","journal-title":"J Exp Anal Behav"},{"key":"R22-4-20210202","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/sj.npp.1301376","article-title":"Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances \u2018liking\u2019 of a sweet reward","volume":"32","author":"Mahler","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R23-4-20210202","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","article-title":"Involvement of the endocannabinoid system in drug addiction","volume":"29","author":"Maldonado","year":"2006","journal-title":"Trends Neurosci"},{"key":"R24-4-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02244907","article-title":"Animal models of drug craving","volume":"112","author":"Markou","year":"1993","journal-title":"Psychopharmacology"},{"key":"R25-4-20210202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0091-3057(95)00187-5","article-title":"Mesolimbic dopaminergic system activity as a function of food reward: a microdialysis study","volume":"53","author":"Martel","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"R26-4-20210202","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00008877-200312000-00002","article-title":"The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats","volume":"14","author":"McLaughlin","year":"2003","journal-title":"Behav Pharmacol"},{"key":"R27-4-20210202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neulet.2007.04.012","article-title":"The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food","volume":"419","author":"Melis","year":"2007","journal-title":"Neurosci Lett"},{"key":"R28-4-20210202","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejphar.2004.08.022","article-title":"Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats","volume":"501","author":"Navarro","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"R29-4-20210202","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Group Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"J Am Med Assoc"},{"key":"R40-4-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J Neurosci Methods"},{"key":"R30-4-20210202","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","article-title":"Modulation of transmitter release via presynaptic cannabinoid receptors","volume":"22","author":"Schlicker","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"R31-4-20210202","first-page":"179","article-title":"SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset","volume":"9","author":"Simiand","year":"1998","journal-title":"Behav Pharmacol"},{"key":"R32-4-20210202","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"R33-4-20210202","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neulet.2003.10.035","article-title":"Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats","volume":"354","author":"Verty","year":"2004","journal-title":"Neurosci Lett"},{"key":"R34-4-20210202","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nn1452","article-title":"How can drug addiction help us understand obesity?","volume":"8","author":"Volkow","year":"2005","journal-title":"Nat Neurosci"},{"key":"R35-4-20210202","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00008877-200509000-00010","article-title":"The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940)","volume":"16","author":"Ward","year":"2005","journal-title":"Behav Pharmacol"},{"key":"R37-4-20210202","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s002130050566","article-title":"\u2018Depression\u2019 increases \u2018craving\u2019 for sweet rewards in animal and human models of depression and craving","volume":"136","author":"Willner","year":"1998","journal-title":"Psychopharmacology"},{"key":"R38-4-20210202","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1098\/rstb.2006.1854","article-title":"Role of brain dopamine in food reward anmd reinforcement","volume":"361","author":"Wise","year":"2006","journal-title":"Philos Trans R Soc Lond B Biol Sci"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FBP.0b013e3282fe8888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:07:39Z","timestamp":1786036059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008877-200805000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0b013e3282fe8888","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}